The difference between convertible debt and stock warrants comes down to one thing: convertible debt is a loan that can turn into shares, and a stock warrant is a standalone right to buy shares at a fixed price. Everything else that matters in a deal, including who gets paid first in a wipeout, when new shares show up on the cap table, and who owes tax at conversion, flows from that single distinction.
Loan Versus Option: The Core Split
A convertible note is legally a loan. The company borrows money, agrees to a principal amount and an interest rate, and books the whole thing as a liability. Interest accrues over the life of the note but typically isn’t paid in monthly installments. The principal and accrued interest either convert into equity later or get repaid in cash.
A stock warrant is not a loan. No money is lent, no interest accrues, and nothing appears on the company’s books as a liability. A warrant is an option contract: it grants the holder the right to buy a specific number of shares at a fixed strike price before a set expiration date. That’s it.
Convertible notes are usually the main event in a seed-stage raise. Warrants are almost always an add-on, issued to sweeten another deal such as a bank loan, an equipment lease, or a preferred stock offering. A lender extending a credit facility might take warrants alongside the loan for a shot at equity upside.
What Each One Costs and What Triggers a Payout
Convertible notes carry an interest rate, typically between 2% and 8% at the seed stage, and a maturity date usually 18 to 36 months out. The conversion trigger is almost always a “qualified financing,” meaning a subsequent equity round that meets a minimum investment threshold spelled out in the note. Two levers control the conversion price:
- A valuation cap puts a ceiling on the effective valuation used to price the investor’s shares. If the cap is $10 million and the next round prices the company at $30 million, the note holder still converts as though the company were worth $10 million.
- A discount rate, typically 15% to 25%, reduces the per-share price the new investors pay. A 20% discount on a $1.00 share price means the note holder converts at $0.80.
The note holder gets whichever calculation produces more shares.
Warrants work differently. There’s no interest, no maturity in the debt sense, and no qualifying-financing trigger. The holder simply decides whether to pay the strike price and take the shares before the warrant expires. Exercise happens only when the stock’s fair market value exceeds the strike price, a condition called being “in the money.” If the stock never gets there, the warrant expires worthless and the holder walks away with nothing lost beyond whatever they paid for the warrant itself, if anything.
Who Gets Paid First If the Company Fails
This is where the loan-versus-option split hits hardest. Because a convertible note is a loan, the holder is a creditor. In a liquidation, creditors get paid before any equity holder sees a dollar. A convertible note holder who hasn’t yet converted sits ahead of preferred shareholders, common shareholders, and warrant holders in the payout line. Only secured creditors with a lien on specific assets typically rank higher.
A warrant holder occupies the lowest rung. Warrants are contractual rights to buy shares that don’t yet exist, so they don’t represent a current claim on any assets. If the company liquidates, the warrant is worthless unless something remains after paying every creditor and every class of shareholder, which almost never happens in a distressed liquidation.
The balance sheet reflects the same split. Convertible debt shows up as a current or long-term liability depending on maturity, which increases the company’s debt-to-equity ratio and shapes how future lenders and investors read its financial health. Warrants are generally classified as equity instruments, or in certain situations involving variable settlement terms, as derivative liabilities. Either way, they don’t represent money the company owes.
For an investor choosing between the two in an early-stage deal, convertible debt gives you a safety net: creditor first, potential shareholder second. Warrants give you upside participation with no downside protection beyond letting the option expire.
Who Controls When Dilution Hits
Convertible debt and warrants hand control over dilution to different parties.
Convertible note conversion is typically automatic and mandatory. When the qualified financing closes, the note converts by operation of the contract. The note holder doesn’t choose whether to convert; the company triggers the event by hitting the financing milestone, and new shares appear on the cap table.
Warrant exercise is voluntary. The holder decides if and when to pay the strike price and claim shares. The company can’t force exercise while the warrant is still alive, and the holder can sit on it indefinitely within the expiration window. That makes warrant-related dilution unpredictable, which complicates planning for future rounds.
The rights each holder carries before conversion or exercise also differ. Convertible note holders often negotiate protective covenants as part of the loan agreement: limits on additional debt, restrictions on asset sales, or rights to receive financial information. Standard creditor stuff. Warrant holders typically get none of that. Their only right is the option to exercise. No voting power, no information rights, no ability to restrict operations.
Both instruments can include anti-dilution provisions that adjust the conversion or exercise price if the company later issues shares at a lower price in a down round. The most common mechanism is a weighted average adjustment, and the specific formula (broad-based versus narrow-based) can shift ownership percentages meaningfully. Founders should read that clause carefully in either instrument before signing.
When the Tax Bill Lands
Convertible debt and warrants also part ways at the moment of conversion or exercise.
Converting a note’s principal into equity is generally not a taxable event for the investor. Tax law treats it as a transformation of ownership rather than a sale. Accrued interest is the exception. Any interest that hasn’t already been included in the investor’s income becomes taxable when it converts, even though the investor receives stock rather than cash. That can create a bill the investor doesn’t have the liquidity to cover.
Exercising a warrant generally triggers taxable income equal to the spread between the fair market value of the shares at exercise and the strike price. A warrant to buy shares at $2.00 that are worth $10.00 at exercise produces $8.00 of taxable spread per share. The character of that income depends on context. For warrants received as compensation for services, the spread is typically taxed as ordinary income. For warrants acquired as part of an investment, treatment depends on the specific terms and holding period.
One more trap on the warrant side: if a company issues warrants or options to service providers, the strike price must be set at or above the stock’s fair market value on the grant date. Getting this wrong triggers penalties under Section 409A of the Internal Revenue Code, including a 20% additional tax on top of regular income tax, plus an interest penalty calculated from the year the compensation was first deferred. Private companies establish fair market value through an independent 409A valuation, which the IRS considers valid for 12 months or until a material event such as a new financing round.
What Happens If Nothing Goes to Plan
The endgame is where the two instruments diverge most sharply.
If a convertible note reaches its maturity date without a qualifying financing, the company technically owes the investor the principal plus accrued interest in cash. Most startups don’t have that cash, so the outcome is usually negotiated. Common paths include extending the maturity date (by far the most frequent outcome), converting at a negotiated valuation without a qualifying round, or layering on bridge financing under revised terms. Outright repayment happens but is uncommon at the seed stage. Leverage flips at maturity: before the deadline, the company controls the timeline; after it passes, the note holder has a legal right to demand repayment, and that right becomes bargaining power over conversion terms or additional sweeteners.
When a warrant expires unexercised, it simply ceases to exist. The holder loses the right to buy shares, and the company has no further obligation. No negotiation, no repayment, no leverage shift. The warrant was always optional, and letting it expire is a valid outcome that costs the holder nothing beyond the opportunity. For the company, expired warrants are a quiet win: potential dilution that never materialized.
A Note on SAFEs
If you’re comparing convertible debt and warrants because you’re deciding how to raise seed capital, one boundary is worth flagging. A SAFE (Simple Agreement for Future Equity), introduced by Y Combinator in 2013 and now the dominant early-stage instrument, is neither of the two things covered here. It’s an agreement to receive equity in a future priced round with no interest rate, no maturity date, and no repayment obligation. That means no debt on the books, no maturity pressure, and no accruing interest, but also no creditor status: SAFE holders typically sit below debt holders in a liquidation and may receive nothing. SAFEs use the same valuation cap and discount mechanics as convertible notes, but the creditor protection that comes with debt was deliberately traded away for simplicity. If someone hands you a SAFE and you were expecting the downside protection of a convertible note, that’s a real difference to price in.